FDA Cracks Down on Hims, Other Telehealth Companies Over Drug Ads
WEDNESDAY, Sept. 17, 2025 — Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs, including popular weight loss medications.
On Tuesday, the U.S. Food and Drug Administration (FDA) released more than 100 warning letters aimed at both drugmakers and online health companies. Among them: Hims & Hers, a telehealth platform that has made a name by selling lower-cost versions of well-known drugs, The Associated Press said.
The agency said Hims crossed the line by telling customers its compounded products contained “the same active ingredient” as Ozempic and Wegovy, even though Hims’ versions are mixed by compounding pharmacies and never reviewed by the FDA.
“Your claims imply that your products are the same as an FDA-approved product when they are not,” the warning letter said.
In response, Hims said it told consumers that compounded medicines aren’t FDA-approved and that it “looks forward to engaging” with the agency.
Compounding is the process of combining, mixing or altering ingredients to create a medication tailored to a patient’s needs, according to the National Library of Medicine.
This is the first time the FDA has targeted online platforms such as Hims directly. The company has long argued that traditional drug advertising rules don’t apply to them.
The move follows an order from President Donald Trump directing federal agencies to ensure drug ads on TV and social media are accurate.
The agency’s concerns go beyond Hims. Regulators also sent letters to Eli Lilly and Novo Nordisk, criticizing a 2024 infomercial with Oprah Winfrey that the FDA said gave a “misleading impression” of weight loss injections such as Wegovy and Zepbound, The AP reported.
While compounding drugs is sometimes allowed when FDA-approved versions are scarce, regulators recently said these drugs no longer qualify as in shortage.
Despite that, some companies continue selling “customized” doses. Hims has defended this, because it is potentially beneficial for certain patients.
Sources
- The Associated Press, Sept. 16, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Hair Samples May Help Spot Mental Health Risks in Sick Kids
WEDNESDAY, Sept. 17 2025 — Children with chronic illnesses face extra challenges, and measuring stress through hair samples may help doctors predict which kids are at...
Can Weed Increase Risk Of Type 2 Diabetes?
TUESDAY, Sept. 16, 2025 — Weed might nearly quadruple a person’s risk of developing type 2 diabetes, a new study says. People who use cannabis have a 3.7 times...
Smoking Increases Risk Of Type 2 Diabetes
MONDAY, Sept. 15, 2025 — Smokers have a higher risk of developing type 2 diabetes, especially if they are genetically predisposed to the condition, a new study says. People...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.